Venture Certified
| 기술평가보증기업(기금) | 2021-01-29 ~ 2023-01-28 | 20210100743 | 2021-01-29 |
| 혁신성장유형 | 2023-01-29 ~ 2026-01-28 | 20230222030122 | 2021-01-29 |
| 혁신성장유형 | 2026-01-29 ~ 2029-01-28 | 20260113030046 | 2021-01-29 |
Revenue CAGR +53.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 10B | 6.8B | 4.3B |
| Operating Profit | 1.0B | 0.3B | 0.4B |
| Net Profit | 0.8B | 0.5B | 0.3B |
| Total Assets | 10B | 8.2B | 5.6B |
| Total Liabilities | 4.7B | 4.0B | 2.8B |
| Total Equity | 5.5B | 4.2B | 2.8B |
▲ 82.3%
▲ 166.3%
▲ 35.6%
▼ 12.6%
▲ 28.5%
| Name | Position | Role |
|---|---|---|
| 김수진 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "충북 청주시",
"ceo_name": "김수진",
"certificate": [
{
"cert_number": "20210100743",
"changes": "",
"disclosure_date": "2021-01-29",
"first_cert_date": "2021-01-29",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2021-01-29 ~ 2023-01-28"
},
{
"cert_number": "20230222030122",
"changes": "",
"disclosure_date": "2023-02-22",
"first_cert_date": "2021-01-29",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2023-01-29 ~ 2026-01-28"
},
{
"cert_number": "20260113030046",
"changes": "",
"disclosure_date": "2026-01-13",
"first_cert_date": "2021-01-29",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2026-01-29 ~ 2029-01-28"
}
],
"company_name": "(주)이투바이오",
"corp_no": "150111-*******",
"financials": {
"2022": {
"capital_stock": 200000000,
"cost_of_sales": 146543000,
"current_assets": 356819000,
"current_liabilities": 282842000,
"gross_profit": 279470000,
"net_income": 31571000,
"net_income_bs": 31571000,
"non_current_assets": 202800000,
"non_current_liabilities": 0,
"non_operating_expenses": 7739000,
"non_operating_income": 117000,
"operating_profit": 39193000,
"revenue": 426013000,
"sga_expenses": 240277000,
"total_assets": 559619000,
"total_equity": 276777000,
"total_liabilities": 282842000
},
"2023": {
"capital_stock": 300000000,
"cost_of_sales": 179418000,
"current_assets": 606143000,
"current_liabilities": 397933000,
"gross_profit": 496987000,
"net_income": 49055000,
"net_income_bs": 48206000,
"non_current_assets": 215853000,
"non_current_liabilities": 0,
"non_operating_expenses": 12657000,
"non_operating_income": 29248000,
"operating_profit": 32464000,
"revenue": 676405000,
"sga_expenses": 464523000,
"total_assets": 821996000,
"total_equity": 424063000,
"total_liabilities": 397933000
},
"2024": {
"capital_stock": 302500000,
"cost_of_sales": 442624000,
"current_assets": 808829000,
"current_liabilities": 111102000,
"gross_profit": 562409000,
"net_income": 81827000,
"net_income_bs": 81353000,
"non_current_assets": 220523000,
"non_current_liabilities": 363710000,
"non_operating_expenses": 14580000,
"non_operating_income": 1008000,
"operating_profit": 95399000,
"revenue": 1005033000,
"sga_expenses": 467010000,
"total_assets": 1029352000,
"total_equity": 554540000,
"total_liabilities": 474812000
}
},
"industry": "화장품 제조업",
"investment": [],
"main_products": "기능성 화장품",
"phone": "1833****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |